Clinical Trial Update: Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial for preventive intravaginal prasterone in postmenopausal women with recurrent UTIs was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopause
• Urinary Tract Infection

Drugs mentioned

• Prasterone (dehydroepiandrosterone (DHEA))

Snippet

Sponsor: Olivia Cardenas-Trowers, M.D. | Conditions: Recurrent Urinary Tract Infection, Postmenopause | Phase 3 | Status: WITHDRAWN